Welcome to the International Conference on Cancer Science, Diagnosis and Therapeutics (ICCSDT 2025): Advancing Integrative Oncology for a Cure-Driven Future.
We are honored to invite researchers, clinicians, healthcare professionals, policymakers, and industry leaders from around the world to participate in this landmark conference scheduled for November 20 & 21, 2025 in Osaka, Japan. This conference aims to serve as a premier platform to explore the latest advancements in cancer science, early diagnosis, and precision therapeutics.
About the Conference
The International Conference on Cancer Science, Diagnosis and Therapeutics 2025 brings together experts from multiple disciplines to foster collaboration and share cutting-edge research focused on integrative oncology. The conference will cover a broad spectrum of topics, including but not limited to:
-
Cancer Biology and Molecular Mechanisms
-
Early Detection and Diagnostic Innovations
-
Precision Oncology and Personalized Therapies
-
Immunotherapy and Targeted Treatments
-
Advances in Radiotherapy and Chemotherapy
-
Biomarkers and Liquid Biopsies
-
Translational Cancer Research
-
Cancer Prevention and Survivorship
-
Clinical Trials and Therapeutic Development
-
Integrative and Complementary Oncology Approaches
Theme of the Conference
Integrative Oncology: Advancing Cancer Research, Early Diagnosis, and Precision Therapies for a Cure-Driven Future
Why Attend the Conference?
Join us at this important gathering to:
-
Learn: Gain insights from keynote addresses, expert panels, and scientific presentations on cutting-edge cancer research and therapeutic innovations.
-
Network: Connect with international researchers, clinicians, policymakers, and pharmaceutical industry experts focused on oncology.
-
Collaborate: Explore cross-disciplinary partnerships to accelerate cancer diagnosis, treatment, and care.
-
Publish: Selected papers will be eligible for publication in conference proceedings and high-impact journals.
Call for Abstracts and Papers
We invite researchers and practitioners to submit abstracts and full papers on topics related to cancer science, diagnosis, and therapeutics. All submissions will be peer-reviewed by an international scientific committee to ensure quality and relevance.
Note
The conference proceedings of the International Conference on Cancer Science, Diagnosis and Therapeutics will be evaluated for indexing in PubMed, Web of Science, SCOPUS, and other reputable scholarly databases. This indexing guarantees global visibility and academic recognition for contributors, facilitating the dissemination of your research to the worldwide oncology community.
Venue
The conference will be held at a prestigious venue in Osaka, Japan, offering world-class facilities for scholarly exchange and collaboration, all set against the backdrop of Bali’s tranquil natural beauty — an ideal environment for an impactful conference.
Contact Information
For inquiries about the International Conference on Cancer Science, Diagnosis and Therapeutics 2025, including sponsorship and registration details, please contact us at contact@srcmeetings.com. We look forward to welcoming you to an inspiring and productive event.
Register Now
Secure your place at the forefront of oncology innovation by registering early. Be part of the global effort to improve cancer diagnosis, treatment, and outcomes.
Important Dates:
-
Final Round of Abstract Submission Closes: Oct 26, 2025
-
Final Registration Closes: Nov 15, 2025
Call for Papers
Researchers and practitioners are encouraged to submit original research, reviews, work-in-progress papers, and posters related to cancer science and therapeutics. Submissions will be rigorously reviewed by the international technical program committee.
Honorarium
We are pleased to offer honorariums to our keynote and invited speakers. To qualify, speakers must secure a minimum of 5 paid registrations (individual or group) from their networks. The honorarium amount will correspond to the number of registrations obtained. We encourage all speakers to promote the conference actively.
Accommodation
Accommodation bookings will be facilitated through the conference for confirmed registrants and speakers only. Assistance with hotel bookings at the conference venue will be provided upon registration confirmation. Availability is limited.
Travel
Please note that due to budget constraints, the conference cannot cover travel expenses for participants or speakers. Attendees are responsible for their own travel arrangements.
Important Note
This conference is independently organized without external sponsorship. Registration fees support essential conference services such as meals, sessions, and networking activities. We appreciate your understanding and support.
Conference sessions
Browse the current session list for International Conference on Cancer Science, Diagnosis and Therapeutics.
Global Oncology Initiatives: Case Studies in Low-Resource Settings
Examine projects aimed at improving cancer care in low-resource settings, highlighting successful strategies for overcoming barriers to diagnosis and treatment.
Rare Cancers: Challenges and Breakthroughs in Treatment
Explore case studies of rare cancers, focusing on the diagnostic challenges and innovative treatment strategies that have led to successful patient outcomes.
Managing Treatment Side Effects: Strategies for Improved Quality of Life
Discuss comprehensive management plans for common treatment side effects, such as chemotherapy-induced neuropathy, using patient cases to illustrate effective interventions.
Patient Advocacy and Involvement: Shaping Research and Treatment
Highlight the crucial role of patient advocates in cancer research and policy-making, showcasing examples where patient involvement has led to more patient-centered care approaches.
Artificial Intelligence in Pathology: Revolutionizing Cancer Diagnostics
Present cases where AI-powered tools have enhanced diagnostic accuracy in pathology, leading to more precise treatment plans and better patient outcomes.
Ethical Dilemmas in Oncology: Navigating Complex Patient Decisions
Through real-life scenarios, discuss ethical challenges faced by oncologists, such as treatment refusal, end-of-life care decisions, and balancing hope with realistic outcomes.
Telemedicine in Oncology: Enhancing Patient Access and Care
Explore how telemedicine has been utilized to provide continuous care for cancer patients, especially during the COVID-19 pandemic, ensuring treatment adherence and timely consultations despite logistical challenges.
Survivorship Programs: Addressing Long-Term Patient Needs
Focus on the development and implementation of survivorship programs that address the long-term physical and psychological needs of cancer survivors, illustrated through patient testimonials and program outcomes.
Radiation Therapy Advances: Precision Techniques in Practice
Examine patient cases where advanced radiation techniques, such as stereotactic body radiotherapy (SBRT), have been employed to target tumors with high precision, minimizing damage to surrounding healthy tissues.
Pediatric Oncology: Tailoring Treatments for Younger Patients
Highlighting unique challenges in pediatric oncology, this session presents cases where age-specific treatment modifications have led to improved survival rates and quality of life for children with cancer.
Integrative Oncology: Complementary Approaches in Patient Care
Explore cases where integrative oncology approaches, combining conventional treatments with complementary therapies, have enhanced patient well-being. Discussions will include the incorporation of nutritional counseling, mindfulness, and acupuncture in comprehensive cancer care plans.
Innovations in Early Detection: Liquid Biopsy Applications
Discuss the implementation of liquid biopsy technologies in early cancer detection. Case studies will illustrate how circulating tumor DNA (ctDNA) analysis has facilitated the identification of minimal residual disease, guiding adjuvant therapy decisions and improving patient prognoses.
Genetic Testing and Counseling: Impact on Familial Cancer Syndromes
This session examines the role of genetic testing in identifying hereditary cancer risks. A compelling case involves a young woman diagnosed with juvenile polyposis syndrome (JPS), whose diagnosis led to early intervention for her sibling, potentially preventing cancer development.
Advancements in Immunotherapy: Transforming Patient Outcomes
Explore groundbreaking immunotherapy treatments through patient case studies, such as the use of pembrolizumab (Keytruda) in high-risk, early triple-negative breast cancer. This therapy has shown remarkable success in preventing cancer recurrence and enhancing survival rates
Personalized Medicine in Oncology: Case Studies in Tailored Therapies
This session delves into real-life applications of personalized medicine, highlighting cases where genomic profiling has led to customized treatment plans. For instance, the TRACERx Lung Study exemplifies how tracking cancer evolution can inform targeted therapies, significantly improving patient outcomes
Abstract submission is closed
This conference is archived, so new abstract submissions are no longer accepted.
Registration details
Registration windows, pricing categories, and key dates for this conference.
Archived conferences remain available for review, but new registrations are disabled.
Featured speakers
Keynote, session, and delegate speakers currently associated with this conference.
KUNWAR RANJEET
Session SpeakerSpeaker biography will be updated soon.
Maria Dalamagka
Session SpeakerSpeaker biography will be updated soon.
Maha Al shaibi
Session SpeakerSultan Qaboos cancer care and research center, surgical oncology, muscat, Oman. oman medical specialty board, surgery, muscat, Oman. Sultan Qaboos Cancer care and research center, surgery, muscat, Oman. Sultan Qaboos...
Mahfouth Almansory
Session SpeakerSpeaker biography will be updated soon.
Tasneem Alarife
Session SpeakerTasneem Al-Areefi, an aspiring researcher in the field of pharmaceutical sciences, carried out a scientific research project focused on the synthesis and antibacterial evaluation of newly designed chalcone derivatives...
Andrea Tedesco
Session SpeakerSpeaker biography will be updated soon.
Danish Jamil
Session SpeakerMy postdoctoral research in e-health systems for gastric cancer diagnosis directly supports SDG 3: Good Health and Well-being, aiming to reduce healthcare costs through improved early detection and better patient outc...
Gunet Eroglu
Session SpeakerDr. Gunet Eroulu' s research focuses on the intersection of neuroscience, education, and technology, with a particular emphasis on dyslexia and learning disorders, She specializes in the development of neurofeedback-b...
Organizing committee members
Conference leadership and organizing contacts currently available in the system.
contact@srcmeetings.com
Osaka, Japan
Nearby attractions will be added soon.
International Conference on Cancer Science, Diagnosis and Therapeutics
contact@srcmeetings.com
For registration, abstract submission, speaker participation, or venue coordination, email our support team or submit your query through the online contact form.